Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers [NA]

View source ↗

Summary

A clinical trial update investigating how NB-UVB phototherapy and steroids modulate CXCL11 and TEMRA biomarkers in vitiligo; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NB-UVB phototherapy (narrowband UVB)
  • Topical corticosteroids (Corticosteroid)

Snippet

Sponsor: Assiut University | Conditions: Vitiligo, NB-UVB | NA | Status: NOT_YET_RECRUITING